Sandy Draper
Stock Analyst at Guggenheim
(2.93)
# 1,612
Out of 5,065 analysts
119
Total ratings
59.38%
Success rate
20.16%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $591.82 | -27.00% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $224.90 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $167.64 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $4.14 | +721.26% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $2.71 | +269.00% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $50.42 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $3.13 | -36.10% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $164.56 | +59.82% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $0.62 | +4,727.81% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $101.91 | -7.76% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $6.96 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $23.76 | +114.65% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $230.63 | -44.07% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $44.01 | +24.97% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $100.90 | +66.50% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $34.71 | -65.43% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $28.17 | +34.90% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $9.73 | +413.87% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $11.48 | +466.20% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $2.36 | +1,425.42% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $244.06 | -31.57% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.31 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $11.17 | +464.01% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $591.82
Upside: -27.00%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $224.90
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $167.64
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $4.14
Upside: +721.26%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.71
Upside: +269.00%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $50.42
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $3.13
Upside: -36.10%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $164.56
Upside: +59.82%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $0.62
Upside: +4,727.81%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $101.91
Upside: -7.76%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $6.96
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $23.76
Upside: +114.65%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $230.63
Upside: -44.07%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $44.01
Upside: +24.97%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $100.90
Upside: +66.50%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $34.71
Upside: -65.43%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $28.17
Upside: +34.90%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $9.73
Upside: +413.87%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $11.48
Upside: +466.20%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $2.36
Upside: +1,425.42%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $244.06
Upside: -31.57%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.31
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $11.17
Upside: +464.01%